Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint.

Prabir Roy-Chaudhury1, Vikas P Sukhatme, Alfred K Cheung

  • 1Division of Nephrology, MSB G-251, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH 45267-0585. prabir.roychaudhury@uc.edu

Journal of the American Society of Nephrology : JASN
|March 28, 2006
PubMed
Summary

Vascular access dysfunction in hemodialysis patients, often caused by venous stenosis from neointimal hyperplasia, lacks novel treatments. This review explores pathogenesis and therapies to improve patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient Centered Technologies to Improve Hemodialysis Vascular Access Cannulation.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Cuffless hemodynamic monitoring with physics-informed machine learning models.

Nature communications·2026
Same author

Response to the "Letter to the Editor: Prebiotic Administration to Chronic Kidney Disease Patients Modifies Their Microbiome and Metabolism".

Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation·2026
Same author

Biofunctionalized Vascular Access Graft Improves Patency and Endothelialization in a Porcine Arteriovenous Model.

Journal of functional biomaterials·2026
Same author

Safety and Effectiveness of the Wrapsody Cell-Impermeable Endoprosthesis to Treat Dysfunctional Arteriovenous Grafts: Results from the Nonrandomized Arm of the WAVE Trial.

Journal of vascular and interventional radiology : JVIR·2026
Same author

One-Year Clinical Outcomes from the Randomized Controlled Arm of the Wrapsody Arteriovenous Access Efficacy (WAVE) Trial.

Journal of vascular and interventional radiology : JVIR·2026

Area of Science:

  • Nephrology
  • Vascular Biology
  • Translational Medicine

Background:

  • Hemodialysis vascular access dysfunction significantly increases morbidity and hospitalizations.
  • Venous stenosis due to neointimal hyperplasia is the primary cause of access failure.
  • Limited novel therapeutic interventions exist despite the clinical burden.

Purpose of the Study:

  • To review hemodialysis vascular access types and the pathology of dysfunction.
  • To explore recent insights into neointimal hyperplasia pathogenesis.
  • To summarize potential novel therapies and suggest future research directions.

Main Methods:

  • Review of existing literature on hemodialysis vascular access.
  • Analysis of pathology and pathogenesis of venous stenosis.

Related Experiment Videos

  • Synthesis of experimental and clinical data on novel therapies.

    • Main Results:

    • Neointimal hyperplasia is a key mechanism in hemodialysis vascular access stenosis.
    • Disparities exist in research and therapeutic translation compared to arterial neointimal hyperplasia.
    • Several experimental and clinical strategies show promise for managing access dysfunction.

    Conclusions:

    • Targeted research into venous neointimal hyperplasia is crucial.
    • Translating advances from interventional cardiology may offer new treatment avenues.
    • Future research should focus on innovative therapies to reduce morbidity and costs associated with access dysfunction.